000 01797cam  2200373zi 4500
0019.889752
003CaOODSP
00520221107172402
006m     o  d f      
007cr |||||||||||
008200724t20202020onc     ob   f00| 0 eng d
020 |a9780660356440
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP40-272/2020E-PDF
24500|aMammalian cell culture-based influenza vaccines : |bsupplemental statement.
264 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2020.
264 4|c©2020
300 |a1 online resource (70 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Vaccins antigrippaux issus de cultures cellulaires de mammifères : déclaration supplémentaire.
500 |aCover title.
500 |a"An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)."
500 |a"Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2020–2021."
500 |aIssued also in HTML format.
504 |aIncludes bibliographical references (pages 64-67).
650 0|aInfluenza vaccines|zCanada.
7102 |aPublic Health Agency of Canada, |eissuing body.
77508|tVaccins antigrippaux issus de cultures cellulaires de mammifères : |w(CaOODSP)9.889753
85640|qPDF|s2.57 MB|uhttps://publications.gc.ca/collections/collection_2020/aspc-phac/HP40-272-2020-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/mammalian-cell-culture-based-influenza-vaccines.html